$CRDO

3 Under-the-Radar AI Stocks Wall Street Is Missing

Credo Technology (CRDO) reported Q4 2026 revenue of $437M, up 157% YoY, with guidance for 80% YoY growth in 2027. Astera Labs (ALAB) saw Q2 2026 revenue of $392.4M, up 104% YoY, with Scorpio X series ramping ahead of schedule. Camtek (CAMT) reported Q2 2026 revenue of $133.24M, up 8% YoY, with a strong order book extending into 2027.

Original reporting
Published Aug 28, 2026, 12:15 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 28, 2026, 12:24 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
3 Under-the-Radar AI Stocks Wall Street Is Missing — source image
Decision brief

The 30-second read

$CRDOBullishMed
01

Why it matters

Each firm delivered earnings beats and forward guidance, providing fresh data points for traders targeting AI supply‑chain plays.

02

Market read

Earnings and guidance releases create immediate trading opportunities in the AI infrastructure niche.

03

What to watch

Potential supply‑chain disruptions in Israel for Camtek and foreign exchange risk for overseas customers.

Relevance 7/10Novelty 7/10Timing: ahead of September 2026 earnings season

Background

The article surveys three mid‑cap AI‑infrastructure companies that are often missed in mainstream AI hype.

Company-level read

Ticker impact

$CRDOBullishHigh confidence
Context

Credo Technology reported Q4 FY2026 results with 157% YoY revenue growth and raised FY2027 revenue guidance, a fresh earnings disclosure.

Expected impact

Potential price appreciation of 10-15% if guidance is sustained.

Evidence & confidence

Quarterly beat and forward guidance exceed consensus, indicating momentum.

$ALABBullishHigh confidence
Context

Astera Labs posted Q2 FY2026 results with record revenue and announced Scorpio X series volume production ahead of schedule.

Expected impact

Possible 8-12% rally on the news.

Evidence & confidence

Earnings beat and new product milestone provide fresh catalyst.

$CAMTBullishMedium confidence
Context

Camtek released Q2 2026 results showing record revenue and a large order backlog extending into 2027.

Expected impact

Likely 5-10% price gain as investors price in future bookings.

Evidence & confidence

Strong order intake but higher risk from regional exposure.

Market effects

Highlights growing demand for AI infrastructure components beyond GPUs, benefiting the broader semiconductor supply chain.

Positive for U.S. mid‑cap tech stocks and may lift related AI‑theme ETFs.

Signals continued global hyperscaler capex, supporting worldwide AI hardware demand.

Counterpoint

High customer concentration and elevated beta could lead to outsized downside if hyperscaler spending slows.

Key entities

  • Credo Technology

    Connectivity and optical components for AI data centers.

  • Astera Labs

    AI fabric switching and signal conditioning.

  • Camtek

    Advanced packaging inspection for HBM and chiplets.

Related articles

$ALABMed

Astera Labs vs. monday.com: Comparing Revenue Trends Between These High-Growth Tech Companies

Astera Labs (ALAB) and monday.com (MNDY) both reported quarterly revenue growth. Astera Labs, which provides semiconductor-based connectivity solutions, saw revenue rise rapidly, surpassing monday.com in Q2 2026. It reported a 39% net income margin and forecasts Q3 revenue of $540M-$560M. monday.com, offering a cloud-native digital work operating system, reported a 6% operating margin and expects Q3 revenue of $368M-$370M, up 16-17% YoY. Both companies have shown consistent growth, with Astera L

$CAMTMedAI 8/10

Camtek (CAMT) Posted Record Q2 Revenue, Is The AI Upside Already Priced In?

Camtek (CAMT) reported record Q2 revenue of $600M+ year-to-date, driven by AI-related advanced packaging demand. The company issued upbeat Q3 guidance, contributing to a 17.55% monthly and 48.74% year-to-date stock price increase. Analysts debate its valuation, with some seeing it as 8.3% undervalued at $171.80, while others suggest it's overvalued based on discounted cash flow models.